Docgo INC Form 4 insider transactions

NASDAQ
Director Etalvina Leite of DocGo Inc. reports the acquisition of restricted stock units and the subsequent sale of shares to cover taxes.
NASDAQ
Director James M. Travers acquired 34,965 restricted stock units and disposed of 391,028 common shares held indirectly through Travers Holdings LLC.
NASDAQ
Director Ira Smedra of DocGo Inc. reports the acquisition of 34,965 restricted stock units and the disposal of 90,999 common stock shares.
NASDAQ
Director Michael J. Burdiek of DocGo Inc. acquired 34,965 shares of common stock through restricted stock units that will vest on December 13, 2025.
NASDAQ
Ely D. Tendler, General Counsel and Secretary of DocGo Inc., reports the acquisition of restricted stock units and the sale of common stock to cover taxes.
NASDAQ
DocGo Inc.'s Chief Compliance Officer, Stephen Sugrue, reported the acquisition of restricted stock units and the withholding of shares for tax obligations.
NASDAQ
DocGo's CFO, Norman Rosenberg, acquired 346,062 restricted stock units and disposed of 19,213 shares to cover tax liabilities.
NASDAQ
DocGo's CEO, Lee Bienstock, received 536,993 restricted stock units and disposed of 86,236 shares to cover tax liabilities.
NASDAQ
Stephen K. Klasko, a director at DocGo Inc., was granted options to purchase 204,082 shares of common stock.
NASDAQ
DocGo's CEO, Lee Bienstock, disposed of shares to cover tax liabilities related to previously granted restricted stock units.
NASDAQ
Stephen Sugrue, Chief Compliance Officer of DocGo Inc., reports the withholding of restricted stock units (RSUs) to cover tax liabilities.
NASDAQ
DocGo's CFO, Norman Rosenberg, disposed of 8,004 shares of common stock to cover tax liabilities related to vested restricted stock units.
NASDAQ
Stephen Sugrue, Chief Compliance Officer of DocGo Inc., reports the withholding of 4,104 common stock units to cover tax liabilities related to previously granted restricted stock units (RSUs).
NASDAQ
Norman Rosenberg, CFO and Treasurer of DocGo Inc., reports the withholding of 8,004 restricted stock units to cover tax liabilities.
NASDAQ
DocGo's CEO, Lee Bienstock, disposed of 18,598 shares of common stock to cover tax liabilities related to previously granted restricted stock units (RSUs).
NASDAQ
DocGo's CEO, Lee Bienstock, disposed of 13,194 shares of common stock to cover tax liabilities related to restricted stock units.
NASDAQ
Stephen Sugrue, Chief Compliance Officer of DocGo Inc., reports the withholding of 4,104 common stock shares to cover tax liabilities related to restricted stock units.
NASDAQ
DocGo's CFO, Norman Rosenberg, disposed of 7,981 shares of common stock to cover tax liabilities related to restricted stock units.
NASDAQ
DocGo's CEO, Lee Bienstock, disposed of shares to cover tax liabilities related to restricted stock units (RSUs).
NASDAQ
Director Michael J. Burdiek of DocGo Inc. recently purchased 10,000 shares of common stock at $3.4 per share.
NASDAQ
Ely D. Tendler, General Counsel and Secretary of DocGo Inc., purchased 10,000 shares of common stock at $3.13 per share on May 13, 2024.
NASDAQ
DocGo's CEO, Lee Bienstock, recently purchased 25,000 shares of the company's common stock at a price of $3.15 per share.
NASDAQ
DocGo's CEO, Lee Bienstock, disposed of shares to cover tax liabilities related to previously granted restricted stock units.
NASDAQ
Director Steven Katz of DocGo Inc. purchased 13,500 shares of common stock at $3.64 per share on March 15, 2024.
NASDAQ
Stephen Sugrue, Chief Compliance Officer of DocGo Inc., reports the acquisition of restricted stock units (RSUs) and adjustments to his beneficial ownership of the company's common stock.
NASDAQ
DocGo's CFO and Treasurer, Norman Rosenberg, reported the acquisition of common stock and restricted stock units (RSUs).
NASDAQ
DocGo's CEO, Lee Bienstock, received 218,579 restricted stock units (RSUs) in lieu of cash incentive payments, according to a recent SEC filing.
NASDAQ
Stanley Vashovsky, a director at DocGo Inc., reported acquiring 21,721 shares and disposing of 7,712,500 shares of common stock on March 15, 2024.
NASDAQ
Director Michael J. Burdiek of DocGo Inc. (DCGO) recently acquired 10,000 shares of common stock at an average price of $3.61 per share, increasing his total holdings.